HOME >> BIOLOGY >> NEWS
Probing the promise and perils of nanoparticles

ANN ARBOR, Mich.---For all its promise, the prospect of using nanoparticles in biomedical applications and consumer products has raised concerns about possible harmful effects of the miniscule materials. Scientists at the University of Michigan are addressing those concerns by investigating how certain kinds of nanoparticles damage cell membranes---enough to cause cell death in some cases---and how the damage can be prevented.

"If you're inventing these sorts of materials, you need to be concerned about their impact," said Mark Banaszak Holl, a U-M professor of chemistry and of macromolecular science and engineering. "We're trying to do both: make important new materials and be excited about what can be done with them, but at the same time, understand what their potential downsides might be." Banaszak Holl and graduate students Pascale Leroueil and Seungpyo Hong will discuss their research at the 229th national meeting of the American Chemical Society in San Diego March 13-17.

In collaboration with other researchers at U-M's Center for Biologic Nanotechnology, Banaszak Holl's lab has been studying nanoparticles known as dendrimers, tiny spheres whose width is ten thousands times smaller than the thickness of a human hair. Dendrimers have shown promise for precisely delivering drugs to their targets inside the body, but high concentrations of these nanoparticles can be toxic. In earlier work, U-M researchers discovered that dendrimers punch nanoscale holes in cell membranes, making the membranes more permeable. At high enough concentrations, they can completely destroy the membranes, killing cells in the process. But the damage can be prevented by engineering dendrimers in particular ways, such as modifying their surfaces to make them neutral instead of charged, the scientists found. And, added Banaszak Holl, "not only does engineering make them less harmful, but it also makes them better at what we want them to do. You don't lose anything; it's all
'"/>

Contact: Nancy Ross-Flanigan
rossflan@umich.edu
734-647-1853
University of Michigan
15-Mar-2005


Page: 1 2

Related biology news :

1. Probing biologys dark matter
2. Insulin grown in plants relieves diabetes in mice; UCF study holds promise for humans
3. Radiation therapy combined with microsurgery shows promise for curing injured spinal cord
4. New proteomics research promises to revolutionize biomedical discovery
5. New research holds promise for protecting cancer patients against infertility
6. New approach to pulmonary hypertension shows promise
7. Modular leukemia drug shows promise in early testing
8. Hepatitis B drug can compromise HIV treatment
9. UCF nanoparticle offers promise for treating glaucoma
10. Identification of genetic risk factor for coeliac disease promises improved treatment
11. Canadian paper innovation holds promise for improved global health safety

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/1/2019)... ... ... Geneious would like to announce it is extending the reach and depth ... Geneious Prime already has a dedicated importer for Vector NTI Advance databases that will ... organised in Geneious in the same way. The next update (expected May 2019) ...
(Date:2/27/2019)... ... ... Fluxion Biosciences, a leading developer of precision solutions for life science research and ... development of its ERASE-Seq liquid biopsy technology. The Phase I grant will have a ... at the Cleveland Clinic. , Liquid biopsies offer the potential to improve treatment of ...
(Date:2/26/2019)... , ... February 26, 2019 , ... ... 2018. In her position as Account Manager, Ms. Baptiste demonstrated her ability to ... customer experience. Ms. Baptiste was responsible for partnering with both the Strategic Development ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... ... , ... Bogey was nine years old when he injured both of his cruciate ligaments. ... caused Bogey to experience problems with his mobility. According to his owners, he could ... on the couch. , His owners, devastated at the sight of Bogey in so much ...
(Date:3/19/2019)... ... ... will review strategies for data management in modular and adaptive clinical trials. , Participants will:, ... 30 percent, reducing cost while increasing quality, achieving clinical site set-up faster , ... reducing risk and impact on trial success, trial teams, and trial execution , ...
(Date:3/19/2019)... ... March 19, 2019 , ... Cirrascale ... announced it has begun offering NVIDIA® DGX-1™ deep learning systems as part of ... to provide the highest performance for artificial intelligence and deep learning research and ...
(Date:3/15/2019)... PAULO and ATLANTA (PRWEB) , ... ... ... completed the acquisition of 100% equity in American Process Inc. and affiliate ... include the Alpena Biorefinery in Alpena Michigan, the Thomaston Biorefinery and R&D ...
Breaking Biology Technology:
Cached News: